The effect of Lipacreon on the nutritional status and the fecal consistency in patients after total gastrectomy

The effect of Lipacreon on the nutritional status and the fecal consistency in patients after total gastrectomy - The effect of Lipacreon on the nutritional status and the fecal consistency in patients after total gastrectomy

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000006842

Enrollment

Registered

2012-04-01

Start date

2012-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients after total gastrectomy for gastric cancer

Interventions

Oral Administration of Lipacreon at every meal for three months

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1 the patients later than one year after total gastrectomy for histologically confirmed gastric cancer without recurrence and except for stage IV 2 over 20 years old 3 performance status 0-2(ECOG scale) 4 informed consent

Exclusion criteria

Exclusion criteria: 1 active double cancer 2 severe or uncontrollable complication 3 decompensated chronic pancreatitis 4 after pancrectomy 5 cystic fibrosis 6 gout 7 allergy to pancrelipase 8 allergy to proteins of pig 9 pregnancy 10 the patients judged as unsuitable for the study

Design outcomes

Primary

Measure	Time frame
effect on nutritional status (total protein, albumin, total cholesterol). effect on wight loss after operation effect on fecal consistency	—

Secondary

Measure	Time frame
adverse event	—

Countries

Japan

Contacts

Public ContactKatsuyoshi kudo

Tohoku University Graduate School of Medicine Division Of Biological-regulation and oncology

kykudo@surg1.med.tohoku.ac.jp

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026